HZNP

Horizon Therapeutics Public Ltd Co

No insider bought or sold Horizon Therapeutics Public Ltd Co in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow HZNP

HZNP over the last year

Prices for HZNP aren't in yet.

HZNP after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

141 insider filings since 2016, newest first

HZNPSell

Andy Pasternak · EVP and Chief Strategy Officer

$3.1M−33.0%Jan 18

HZNPSell

Aaron Cox · EVP and CFO

$4.1M−99.0%Jan 17

HZNPSell

Jeffrey W Sherman · EVP and Chief Medical Officer

$762K−3.0%Jan 12

HZNPSell

Jeffrey W Sherman · EVP and Chief Medical Officer

$588K−2.0%Jan 6

HZNPSell

Andy Pasternak · EVP and Chief Strategy Officer

$3.4M−47.0%Dec 14

HZNPSell

Jeffrey W Sherman · EVP and Chief Medical Officer

$3.2M−16.0%Dec 13

HZNPBuy

Sean M. Clayton · EVP and General Counsel

$50KAug 8

HZNPSell

Andy Pasternak · EVP and Chief Business Officer

$400K−12.0%Jul 29

HZNPSell

Elizabeth H.z. Thompson · EVP, Research, Development

$511K−46.0%Jul 20

HZNPSell

Andy Pasternak · EVP and Chief Business Officer

$65K−2.0%Jun 13

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.3M−4.0%Jun 3

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.3M−4.0%Jun 2

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.3M−3.0%May 20

HZNPSell

Timothy P Walbert · Chair, President and CEO

$1.6M−2.0%May 13

HZNPSell

Timothy P Walbert · Chair, President and CEO

$672K−1.0%May 10

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.4M−3.0%May 4

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.7M−3.0%Apr 22

HZNPSell

Paul W. Hoelscher · EVP and CFO

$5.7M−26.0%Apr 22

HZNPSell

Elizabeth H.z. Thompson · EVP, Research, Development

$936K−38.0%Apr 20

HZNPSell

Michael A. Desjardin · EVP, Technical Operations

$2.3M−20.0%Apr 14

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.8M−3.0%Apr 8

HZNPSell

Paul W. Hoelscher · EVP and CFO

$33.8M−69.0%Apr 8

HZNPSell

Jeffrey W Sherman · EVP and Chief Medical Officer

$4.6M−15.0%Apr 8

HZNPSell

Timothy P Walbert · Chair, President and CEO

$5.3M−6.0%Apr 1

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.7M−3.0%Mar 25

HZNPSell

Paul W. Hoelscher · EVP and CFO

$4.4M−15.0%Mar 25

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.5M−3.0%Mar 11

HZNPSell

Michael A. Desjardin · EVP, Technical Operations

$3.4M−25.0%Mar 4

HZNPSell

Andy Pasternak · EVP and Chief Business Officer

$124K−3.0%Feb 18

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.4M−3.0%Feb 11

HZNPSell

Timothy P Walbert · Chair, President and CEO

$11.4M−13.0%Jan 31

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.3M−3.0%Jan 14

HZNPSell

Andy Pasternak · EVP and Chief Business Officer

$795K−16.0%Jan 6

HZNPSell

Timothy P Walbert · Chair, President and CEO

$8.1M−10.0%Jan 4

HZNPSell

Paul W. Hoelscher · EVP and CFO

$943K−5.0%Dec 30

HZNPSell

Miles W Mchugh · SVP, Princ. Acctg Officer

$8.5M−69.0%Dec 3

HZNPSell

Timothy P Walbert · Chair, President and CEO

$5.1M−6.0%Dec 1

HZNPSell

Andy Pasternak · EVP and Chief Business Officer

$3.4M−56.0%Nov 5

HZNPSell

Barry Moze · EVP, Chief Admin. Officer

$8.5M−50.0%Nov 5

HZNPSell

Timothy P Walbert · Chair, President and CEO

$3.0M−3.0%Nov 3

HZNPSell

Timothy P Walbert · Chair, President and CEO

$5.5M−6.0%Oct 1

HZNPSell

Jeffrey W Sherman · EVP and Chief Medical Officer

$5.1M−18.0%Sep 23

HZNPSell

Brian K Beeler · EVP and General Counsel

$3.0M−31.0%Sep 17

HZNPSell

Andy Pasternak · EVP and Chief Business Officer

$2.5M−50.0%Sep 13

HZNPSell

Brian K Beeler · EVP and General Counsel

$7.9M−45.0%Aug 17

HZNPSell

Elizabeth H.z. Thompson · EVP, Research, Development

$802K−35.0%Aug 6

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.5M−3.0%Jul 30

HZNPSell

Michael G Grey · Director

$500K−7.0%Jul 23

HZNPSell

Barry Moze · EVP, Chief Admin. Officer

$3.2M−33.0%Jul 9

HZNPSell

Timothy P Walbert · Chair, President and CEO

$2.3M−3.0%Jul 2

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.